Why even more Americans are arming up with AR-15 guns

Why even more Americans are arming up with AR-15 guns


The AR-15 is one of the most controversial weapons in America.

Lightweight and easily customizable AR-15 style weapons have skyrocketed in popularity in recent years, taking center stage at gun ranges and shooting competitions across the country. Advocates say the weapons are a symbol of freedom, and important for personal safety.

“I am smaller and less capable to handle violence, and a firearm is the great equalizer,” said Dianna Muller founder of the DC Project, which advocates for firearm education. “I go to bed comfortably and do not worry about it at all because I have an AR-15 beside my bed.”

As of 2018, there were an estimated 393 million civilian-owned firearms in the U.S., according to the Switzerland-based Small Arms Survey, a government-backed global organization. As of 2020, there were about 20 million AR-15-style weapons in the country, according to the National Shooting Sports Foundation, a trade association.

Firearm manufacturers have seen revenue surge, taking in about $1 billion from the sale of AR-15 style weapons in the past decade.

The weapons have been involved in a number of mass shootings, including at an elementary school in Uvalde, Texas, earlier this year that killed 19 children and 2 teachers. Critics argue the weapons are aggressively marketed by gun companies targeting at-risk young males.

In an effort to stem the flow of mass shootings, the U.S. House of Representatives last month passed legislation that would ban assault weapons. That measure is likely to face defeat in the Senate.

So what’s behind the popularity of the AR-15, and what responsibility do gun makers have when their products are used in mass shootings? Watch the video to learn more.

Watch more:

Can The North Face compete with Patagonia?
How airlines are dealing with rising air rage cases



Source

More than 20,000 people are taking Eli Lilly’s weight loss pill Foundayo, CEO says
Business

More than 20,000 people are taking Eli Lilly’s weight loss pill Foundayo, CEO says

More than 20,000 people have started taking Eli Lilly‘s GLP-1 pill Foundayo in its first few weeks on the market, Lilly CEO Dave Ricks told CNBC on Thursday. The FDA approved Lilly’s once-daily pill Foundayo earlier this month, making it the second oral GLP-1 drug behind Novo Nordisk’s Wegovy pill. Investors have been closely tracking […]

Read More
Lawyers to the wealthy warn that AI legal advice comes with serious risks
Business

Lawyers to the wealthy warn that AI legal advice comes with serious risks

Displeased couple having problems during a meeting with their agent in the office. Skynesher | E+ | Getty Images A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. Lawyer Tasha Dickinson said […]

Read More
Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket
Business

Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket

David Ricks, chief executive officer of Eli Lilly & Co., at the Semafor World Economy Summit during the International Monetary Fund (IMF) and World Bank Spring meetings in Washington, DC, US, on Friday, April 17, 2026. Aaron Schwartz | Bloomberg | Getty Images Eli Lilly on Thursday reported first-quarter earnings and revenue that blew past […]

Read More